http://www.jabs.org.uk/

CryShame Press Release - 9 March 2013

http://www.cryshame.co.uk

Important new research ( http://www.plosone.org/article/info:doi/10.1371/journal.pone.0058058 ) reports similar findings to the work of Dr Andrew Wakefield in the 1998 Lancet and in subsequent paper in the early 2000s

Groundbreaking new research examines the molecular structure of inflammatory material taken from the bowels of autistic children. It compares the structure of diseased biopsies in the autistic children with biopsies from three groups of non-autistic children with Crohn’s disease, ulcerative colitis, and histologically normal (the controls).

Previous research confirmed the pathological and immunological make-up of biopsies of autistic children, but had not to date identified its specific molecular structure. Children with the four different conditions have been found to have similar findings of inflammation. But it was not clear if this was the same condition shared by all four groups; or if a distinct condition was specific to autistic children alone; or if indeed there was no disease in the autistic group. A molecular analysis of the genetic structure found in the inflamed bowel tissue of children in each group would provide initial answers to these questions.

To date government and medical scientists continue to deny an association between autism and bowel disease. In the UK there is currently no research into the association between autism and chronic bowel disease. This has been the predicament since the government and medical profession waged a campaign to discredit research from the Royal Free Hospital led by Dr Andrew Wakefield in 1998 and the early 2000s that first identified the presence of bowel disease in autistic children.

Following years of denial from government and the medical profession, new research published in the leading online journal PLOS ONE confirms the presence of intestinal disease in autistic children and supports reports from many parents of ongoing painful gastric problems in their autistic children.

The research studied bowel samples from 25 autistic, 8 Crohn's, 5 ulcerative colitis and 15 normal control children and found that inflammatory material obtained from the biopsies of autistic children had a distinct molecular structure that was different from the other three groups.

This is an important finding of the distinct genetic expression that has now been identified in autistic children as distinct from non-autistic children with Crohns, ulcerative colitis and normal bowels. It paves the way for future research into the specific molecular structure of the inflammation affecting autistic children and hopefully will lead to new interventions and treatment.

Background Notes

1. The first paper to bring to public attention the presence of bowel disease in autistic children was Wakefield AJ, (1998) 'Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children'.The Lancet published this paper in 1998 but subsequently retracted it in 2010 after the GMC found Dr Wakefield and Professor Walker-Smith guilty of serious professional misconduct.

2. Several former colleagues went on in the early 2000s to study the nature of the bowel disease in autistic children, focusing on the pathology of gut tissue and the presence of autoimmune features in the bowel (eg Furlano et al (2001) 'Colonic CD8 and ?? T-cell infiltration with epithelial damage in children with autism', Journal of Pediatrics, Vol. 138, 3).

3. The senior research leader of the Lancet and subsequent papers was Professor John Walker-Smith who in March 2012 had all the charges of professional misconduct made by the GMC quashed on appeal by Justice Mitting in the High Court.

4. Government Minister admits more needs to be done to research autism and bowel disease. Read letter here.

PLOS ONE Journal Information

PLOS ONE (eISSN-1932-6203) is an international, peer-reviewed, open-access, online publication. PLOS ONE welcomes reports on primary research from any scientific discipline. It provides:
•Open-access—freely accessible online, authors retain copyright
•Fast publication times
•Peer review by expert, practicing researchers
•Post-publication tools to indicate quality and impact
•Community-based dialogue on articles
•Worldwide media coverage